Overview Of Value Stocks In The Consumer Defensive Sector

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Understanding Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The following stocks are considered to be notable value stocks in the consumer defensive sector:

  1. China Online Education Gr (NYSE:COE) – P/E: 3.47
  2. Albertsons Companies (NYSE:ACI) – P/E: 10.0
  3. Sunlands Technology (NYSE:STG) – P/E: 0.72
  4. Herbalife Nutrition (NYSE:HLF) – P/E: 7.04
  5. Newell Brands (NASDAQ:NWL) – P/E: 9.78

Most recently, China Online Education Gr reported earnings per share at $-0.67, whereas in Q1 earnings per share sat at $-0.94. Albertsons Companies’s earnings per share for Q1 sits at $1.0, whereas in Q4, they were at 0.75. Most recently, the company reported a dividend yield of 1.81%, which has increased by 0.43% from last quarter’s yield of 1.38%.

Sunlands Technology’s earnings per share for Q2 sits at $1.26, whereas in Q1, they were at 2.14. This quarter, Herbalife Nutrition experienced a decrease in earnings per share, which was $0.99 in Q1 and is now $0.96. Its most recent dividend yield is at 1.71%, which has decreased by 1.82% from 3.53% in the previous quarter.

This quarter, Newell Brands experienced an increase in earnings per share, which was $0.36 in Q1 and is now $0.57. The company’s most recent dividend yield sits at 4.63%, which has increased by 0.68% from 3.95% last quarter.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Total
0
Shares
Related Posts
Read More

CytoMed Therapeutics Announces China Research Collaboration To Enhance Its Allogeneic CAR γδ T In Vivo Persistency; The MOU Signed By Cytomed And Hangzhou CNK Therapeutics Co., Ltd Is The First Of Several Collaborative Efforts In North Asia

The MOU signed by CytoMed and Hangzhou CNK Therapeutics Co., Ltd is the first of several collaborative efforts in North Asia.   SINGAPORE, Aug. 15, 2023 /PRNewswire/ -- CytoMed Therapeutics

GDTC